The DEXLIFE study methods: identifying novel candidate biomarkers that predict progression to type 2 diabetes in high risk individuals

The DEXLIFE study methods : identifying novel candidate biomarkers that predict progression to type 2 diabetes in high risk individuals

Andersen, Gregers Stig Tig (author): Steno Diabetes Center, Gentofte, Denmark

Cederberg, Henna (author): Department of Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland

Oresic, Matej, 1967- (author): Örebro universitet,Institutionen för medicinska vetenskaper,Steno Diabetes Center, Gentofte, Denmark

Esteller, Manel B. (author): Cancer Epigenetics and Biology Program, Spanish Biomedical Research Centre Network for Epidemiology and Public Health, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain

Zorzano, Antonio (author): Institute for Research in Biomedicine, Barcelona, Spain; Departament de Bioquímica I Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain

Carr, Bernadette M. (author): Voluntary Health Insurance Board, Dublin, Ireland

Walker, Mark G. (author): University of Newcastle-on-Tyne, Newcastle, United Kingdom

O'Gorman, Donal J. (author): Centre for Preventive Medicine, School of Health and Human Performance, Dublin City University, Dublin, Ireland

(creator_code:org_t)

Elsevier, 2014
2014
English.
In: Diabetes Research and Clinical Practice. - : Elsevier. - 0168-8227 .- 1872-8227. ; 106:2, s. 383-389

Related links:: https://urn.kb.se/re...; show more...; https://doi.org/10.1...; show less...

Abstract Subject headings

The incidence of type 2 diabetes (T2D) is rapidly increasing worldwide and T2D is likely to affect 592 million people in 2035 if the current rate of progression is continued. Today, patients are diagnosed with T2D based on elevated blood glucose, either directly or indirectly (HbA1c). However, the information on disease progression is limited. Therefore, there is a need to identify novel early markers of glucose intolerance that reflect the underlying biology and the overall physiological, metabolic and clinical characteristics of progression towards diabetes. In the DEXLIFE study, several clinical cohorts provide the basis for a series of clinical, physiological and mechanistic investigations in combination with a range of--omic technologies to construct a detailed metabolic profile of high-risk individuals across multiple cohorts. In addition, an exercise and dietary intervention study is conducted, that will assess the impact on both plasma biomarkers and specific functional tissue-based markers. The DEXLIFE study will provide novel diagnostic and predictive biomarkers which may not only effectively detect the progression towards diabetes in high risk individuals but also predict responsiveness to lifestyle interventions known to be effective in the prevention of diabetes.

By the author/editor: Andersen, Greger ...; Thybo, Tanja; Cederberg, Henna; Oresic, Matej, 1 ...; Esteller, Manel ...; Zorzano, Antonio; show more...; Carr, Bernadette ...; Walker, Mark G.; Cobb, Jeff E.; Clissmann, C.; O'Gorman, Donal ...; Nolan, John J.; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Endocrinology an ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.